Literature DB >> 2671054

Comparison of immunofluorescence and enzyme linked immunosorbent assays for diagnosing Lyme disease.

S J Cutler1, D J Wright.   

Abstract

A new enzyme linked immunosorbent assay (ELISA) method was assessed in parallel with an indirect immunofluorescence assay (IFA) for the serological testing of specimens submitted for detection of Lyme disease. Wells of an ELISA microtitre plate were coated with sonicated whole cells of Borrelia burgdorferi in carbonate buffer. After overnight incubation at 4 degrees C the plates were washed three times, then incubated at 37 degrees C for an hour sequentially with a blocking solution, diluted test serum, anti-human IgG horseradish peroxidase conjugate, and finally for half an hour at room temperature with o-phenylenediamine substrate before being read at 492 nm. Absorbance results were converted into arbitrary ELISA units. Of a total of 1760 sera, 146 (8.3%) were positive: of these 92 (63%) were positive by both methods, five (3.4%) by IFA alone, and 49 (33.6%) by ELISA alone. The ELISA was better suited for testing large numbers of specimens and easier to interpret than IFA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671054      PMCID: PMC1142067          DOI: 10.1136/jcp.42.8.869

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

Review 1.  Lyme disease.

Authors:  P M O'Neill; D J Wright
Journal:  Br J Hosp Med       Date:  1988-10

2.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

3.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

4.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

  4 in total
  8 in total

Review 1.  Lyme disease in paediatrics.

Authors:  B Cryan; D J Wright
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

2.  Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node.

Authors:  N R Cary; B Fox; D J Wright; S J Cutler; L M Shapiro; A A Grace
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

3.  Interlaboratory comparison of titers of antibody to Borrelia burgdorferi and evaluation of a commercial assay using canine sera.

Authors:  R T Greene; D A Hirsch; P L Rottman; T M Gerig
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

4.  Comparison of seven commercial kits for detection of antibodies to Borrelia burgdorferi.

Authors:  J L Schmitz; C S Powell; J D Folds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

5.  2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

6.  Relapsing fever and its serological discrimination from Lyme borreliosis.

Authors:  P M Rath; G Rögler; A Schönberg; H D Pohle; F J Fehrenbach
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

7.  Predictive value of serology in diagnosing Lyme borreliosis.

Authors:  S J Cutler; D J Wright
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

8.  Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.

Authors:  Sissy Therese Sonnleitner; Martina Prelog; Bianca Jansen; Chantal Rodgarkia-Dara; Sarah Gietl; Carmen Maria Schönegger; Stephan Koblmüller; Christian Sturmbauer; Wilfried Posch; Giovanni Almanzar; Hanna Jury; Tom Loney; Alexander Tichy; Norbert Nowotny; Gernot Walder
Journal:  Transbound Emerg Dis       Date:  2021-05-27       Impact factor: 4.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.